Translate this page into:
Letter to the Editor
doi:
10.4103/2278-330X.195347
Pregnancy on tamoxifen: Case-report and review of literature
1
Department of Medical Oncology, Tata Memorial Centre, Mumbai, Maharashtra
2
Department of Radiotherapy, Tata Memorial Centre, Mumbai, Maharashtra
3
Department of Surgical Pathology, Tata Memorial Centre, Mumbai, Maharashtra
*Corresponding author: Dr. Jyoti Bajpai. dr_jyotibajpai@yahoo.co.in
MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)
Disclaimer:
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
References
- Iguchi T, Hirokawa M, Takasugi N. Occurrence of genital tract abnormalities and bladder hernia in female mice exposed neonatally to tamoxifen. Toxicology 1986;42:1-11.
- Tewari K, Bonebrake RG, Asrat T, Shanberg AM. Ambiguous genitalia in infant exposed to tamoxifen in utero. Lancet 1997;350:183.
- Oksüzoglu B, Güler N. An infertile patient with breast cancer who delivered a healthy child under adjuvant tamoxifen therapy. Eur J Obstet Gynecol Reprod Biol 2002;104:79.
- Isaacs RJ, Hunter W, Clark K. Tamoxifen as systemic treatment of advanced breast cancer during pregnancy - Case report and literature review. Gynecol Oncol 2001;80:405-8.
- Halakivi-Clarke L, Cho E, Onojafe I, Liao DJ, Clarke R. Maternal exposure to tamoxifen during pregnancy increases carcinogen-induced mammary tumorigenesis among female rat offspring. Clin Cancer Res 2000;6:305-8.
- Pugh DM, Sumano HS. The anti-implantation action of tamoxifen in mice. Arch Toxicol Suppl 1982;5:209-13.
- Lim YC, Li L, Desta Z, Zhao Q, Rae JM, Flockhart DA, et al. Endoxifen, a secondary metabolite of tamoxifen, and 4-OH-tamoxifen induce similar changes in global gene expression patterns in MCF-7 breast cancer cells. J Pharmacol Exp Ther 2006;318:503-12.
- Kedia-Mokashi N, Makawy AE, Saxena M, Balasinor NH. Chromosomal aberration in the post-implantation embryos sired by tamoxifen treated male rats. Mutat Res 2010;703:169-73.
- Clark RM, Chua T. Breast cancer and pregnancy: The ultimate challenge. Clin Oncol (R Coll Radiol) 1989;1:11-8.
- Poulet FM, Roessler ML, Vancutsem PM. Initial uterine alterations caused by developmental exposure to tamoxifen. Reprod Toxicol 1997;11:815-22.
- Barthelmes L, Gateley CA. Tamoxifen and pregnancy. Breast 2004;13:446-51.
- Cullins SL, Pridjian G, Sutherland CM. Goldenhar′s syndrome associated with tamoxifen given to the mother during gestation. JAMA 1994;271:1905-6.
- Berger JC, Clericuzio CL. Pierre Robin sequence associated with first trimester fetal tamoxifen exposure. Am J Med Genet A 2008;146A: 2141-4.
- Clark S. Prophylactic tamoxifen. Lancet 1993;342:168.
- Patterson JS, Settatree RS, Adam HK, Kemp JV. Serum concentrations of tamoxifen and major metabolite during longterm nolvadex therapy, correlated with clinical response. Eur J Cancer Suppl 1980;1:89-92.
- MacCallum J, Cummings J, Dixon JM, Miller WR. Concentrations of tamoxifen and its major metabolites in hormone responsive and resistant breast tumours. Br J Cancer 2000;82:1629-35.
- Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 6 th ed. Philadelphia: Williams and Wilkins; 2002. p. 1307-13.